Treatment of late stage sleeping sickness caused by T.b. gambiense: a new approach to the use of an old drug

Treatment of late stage sleeping sickness caused by T.b. gambiense: a new approach to the use of an old drug

Bibliographic Details
Main Author:	Swiss Medical Weekly
Format:	Article
Language:	English
Published:	SMW supporting association (Trägerverein Swiss Medical Weekly SMW) 2002-02-01
Series:	Swiss Medical Weekly
Subjects:	Melarsoprol Sleeping sickness Human African trypanosomiasis
Online Access:	https://www.smw.ch/index.php/smw/article/view/137

Similar Items

High Failure Rates of Melarsoprol for Sleeping Sickness, Democratic Republic of Congo
by: Jo Robays, et al.
Published: (2008-06-01)

Chimerization at the AQP2–AQP3 locus is the genetic basis of melarsoprol–pentamidine cross-resistance in clinical Trypanosoma brucei gambiense isolates
by: Fabrice E. Graf, et al.
Published: (2015-08-01)

Challenges facing the elimination of sleeping sickness in west and central Africa: sustainable control of animal trypanosomiasis as an indispensable approach to achieve the goal
by: Gustave Simo, et al.
Published: (2015-12-01)

The Drugs of Sleeping Sickness: Their Mechanisms of Action and Resistance, and a Brief History
by: Harry P. De Koning
Published: (2020-01-01)

Sleeping sickness and its relationship with development and biodiversity conservation in the Luangwa Valley, Zambia
by: Neil E Anderson, et al.
Published: (2015-04-01)

Trypanosome infection rates in tsetse flies in the “silent” sleeping sickness focus of Bafia in the Centre Region in Cameroon
by: Gustave Simo, et al.
Published: (2015-10-01)

Tackling Sleeping Sickness: Current and Promising Therapeutics and Treatment Strategies
by: Miebaka Jamabo, et al.
Published: (2023-08-01)

Highly Localized Enrichment of <i>Trypanosoma brucei</i> Parasites Using Dielectrophoresis
by: Devin Keck, et al.
Published: (2020-06-01)

African Trypanosomiasis Gambiense, Italy
by: Zeno Bisoffi, et al.
Published: (2005-11-01)

Clinical Study on the Melarsoprol-Related Encephalopathic Syndrome: Risk Factors and HLA Association
by: Jorge Seixas, et al.
Published: (2020-01-01)

New Drugs for Human African Trypanosomiasis: A Twenty First Century Success Story
by: Emily A. Dickie, et al.
Published: (2020-02-01)

Antitrypanosomal activity of Argemone mexicana extract and fractions in the animal model of Trypanosoma brucei brucei infection
by: Chukwu Ifeoma L., et al.
Published: (2022-12-01)

Comparative analysis of cerebrospinal fluid from the meningo-encephalitic stage of T. b. gambiense and rhodesiense sleeping sickness patients using TMT quantitative proteomics
by: Natalia Tiberti, et al.
Published: (2015-09-01)

Estimating the economic and social consequences for patients diagnosed with human African trypanosomiasis in Muchinga, Lusaka and Eastern Provinces of Zambia (2004–2014)
by: Allan Mayaba Mwiinde, et al.
Published: (2017-10-01)

Trypanocidal Activity of Marine Natural Products
by: Amy J. Jones, et al.
Published: (2013-10-01)

Molecular identification of Trypanosoma brucei gambiense in naturally infected pigs, dogs and small ruminants confirms domestic animals as potential reservoirs for sleeping sickness in Chad
by: Vourchakbé Joël, et al.
Published: (2020-01-01)

Gambiense Human African Trypanosomiasis Sequelae after Treatment: A Follow-Up Study 12 Years after Treatment
by: Junior Mudji, et al.
Published: (2020-01-01)

From Colonial Research Spirit to Global Commitment: Bayer and African Sleeping Sickness in the Mirror of History
by: Ulrich-Dietmar Madeja, et al.
Published: (2020-03-01)

Haemoparasitic Infections in Cattle from a <i>Trypanosoma brucei</i> Rhodesiense Sleeping Sickness Endemic District of Eastern Uganda
by: Enock Matovu, et al.
Published: (2020-02-01)

Estimates of the duration of the early and late stage of gambiense sleeping sickness
by: Chandramohan Daniel, et al.
Published: (2008-02-01)

Mapping sleeping sickness in Western Africa in a context of demographic transition and climate change
by: Cecchi G., et al.
Published: (2009-06-01)

Evaluation of the micro-CATT, CATT/Trypanosoma brucei gambiense, and LATEX/T. b. gambiense methods for serodiagnosis and surveillance of human African trypanosomiasis in West and Central Africa
by: Truc Philippe, et al.
Published: (2002-01-01)

Immune trypanolysis test as a promising bioassay to monitor the elimination of gambiense human African trypanosomiasis
by: Dama Emilie, et al.
Published: (2019-01-01)

Healthcare Management of Human African Trypanosomiasis Cases in the Eastern, Muchinga and Lusaka Provinces of Zambia
by: Allan Mayaba Mwiinde, et al.
Published: (2022-09-01)

Positively selected modifications in the pore of TbAQP2 allow pentamidine to enter Trypanosoma brucei
by: Ali H Alghamdi, et al.
Published: (2020-08-01)

The role of domestic animals in the epidemiology of human african trypanosomiasis in Ngorongoro conservation area, Tanzania
by: Juan P. Ruiz, et al.
Published: (2015-10-01)

Detection of trypanosomes in suspected sleeping sickness patients in Uganda using the polymerase chain reaction
by: J.W Kyambadde, et al.

Human African Trypanosomiasis Transmission, Kinshasa, Democratic Republic of Congo
by: Gustave Simo, et al.
Published: (2006-12-01)

Modelling host-Trypanosoma brucei gambiense interactions in vitro using human induced pluripotent stem cell-derived cortical brain organoids [version 2; peer review: 2 approved]
by: Juan F. Quintana, et al.
Published: (2023-07-01)

Pathogenicity and virulence of African trypanosomes: From laboratory models to clinically relevant hosts
by: Liam J. Morrison, et al.
Published: (2023-12-01)

Fexinidazole for Human African Trypanosomiasis, the Fruit of a Successful Public-Private Partnership
by: Sonja Bernhard, et al.
Published: (2022-10-01)

Quantitative evaluation of the strategy to eliminate human African trypanosomiasis in the Democratic Republic of Congo
by: Kat S. Rock, et al.
Published: (2015-10-01)

Systematic Review and Meta-Analysis on Knowledge Attitude and Practices on African Animal Trypanocide Resistance
by: Keneth Iceland Kasozi, et al.
Published: (2022-08-01)

Plant Terpenoids as Hit Compounds against Trypanosomiasis
by: Raquel Durão, et al.
Published: (2022-03-01)

Experimental evidence that immune trypanolysis using the LiTat 1.3 and LiTat 1.5 variant antigen types is not specific to Trypanosoma brucei gambiense in pigs
by: Ilboudo Kadidiata, et al.
Published: (2022-01-01)

Effects of Synthetic Ligustrazine-Based Chalcone Derivatives on <i>Trypanosoma brucei brucei</i> and <i>Leishmania</i> spp. Promastigotes
by: Abdulsalam A. M. Alkhaldi
Published: (2023-06-01)

Trypanosome spliced leader RNA for diagnosis of acoziborole treatment outcome in gambiense human African trypanosomiasis: A longitudinal follow-up studyResearch in context
by: Ipos Ngay Lukusa, et al.
Published: (2022-12-01)

APOL1 renal risk variants have contrasting resistance and susceptibility associations with African trypanosomiasis
by: Anneli Cooper, et al.
Published: (2017-05-01)

Evaluating long-term effectiveness of sleeping sickness control measures in Guinea
by: Abhishek Pandey, et al.
Published: (2015-10-01)

A doença de Chagas: repercussões de uma descoberta científica brasileira em Portugal, 1909-1924
by: Ewerton Luiz Figueiredo Moura da Silva
Published: (2022-06-01)